Sustained benefit of stenting chronic coronary occlusion: long-term clinical follow-up of the Stenting in Chronic Coronary Occlusion (SICCO) study
Per Anton Sirnes, MD,
Svein Golf, MD, PhDa,
Yngvar Myreng, MD, PhDa,
Per Mølstad, MD, PhDa,
Per Albertsson, MD, PhD*,
Arild Mangschau, MD, PhD ,
Knut Endresen, MD, PhD and
John Kjekshus, MD, PhD
a The Feiring Heart Clinic, Feiring, Norway
* Sahlgrenska University Hospital, Göteborg, Sweden
Ullevål Hospital, Oslo, Norway
National Hospital, Oslo, Norway

View larger version (12K):
[in a new window]
|
Figure 1 Survival without major adverse clinical events (death, AMI, TVR, reocclusion). Solid line = stent group; dashed line = PTCA group.
|
|

View larger version (11K):
[in a new window]
|
Figure 2 Target vessel revascularization. Solid line= stent group; dashed line = PTCA group.
|
|
|